fbpx mmnews


‘Remdesivir’ drug fails to reduce mortality among COVID-19 patients

LONDON: A World Health Organization (WHO) has revealed that the ‘Remdesivir’, which was said to be a touted drug authorized for treatment of norovirus fails to prevent death among patients. The study was conducted in 30 counties on more than

Gilead sets price tag for COVID-19 drug remdesivir

LOS ANGELES: Gilead Sciences priced its COVID-19 antiviral remdesivir at $2,340 per patient in developed countries and agreed to send nearly all of its supply of the drug to the United States over the next three months. The price tag

Gilead targets remdesivir for two million COVID-19 patients

WASHINGTON: Gilead Sciences has doubled its target and is now expecting to supply enough of its antiviral drug remdesivir by year-end to treat more than two million COVID-19 patients. The company also hopes to start trials in August of an

COVID-19 study details benefits of treatment with remdesivir

WASHINGTON: A new study has found an anti-viral drug remdesivir to cut recovery times in coronavirus patients, showing the medication has benefits. Complete results from the research, which was carried out by US government agency the National Institute of Allergy

Pakistan to produce anti-viral drug Remdesivir within two months

ISLAMABAD: A Pakistani pharmaceutical company will manufacture the anti-viral drug Remdesivir which had been approved to treat coronavirus patients. Special Assistant on National Health Services Dr Zafar Mirza said the drug will be manufactured within two months and will also

Japan approves remdesivir drug for COVID-19 treatment

TOKYO: Japan approved remdesivir as a treatment for COVID-19, making it the country’s first officially authorised drug to tackle the coronavirus disease. Japan reached the decision just three days after US drugmaker Gilead Sciences filed for fast-track approval for the

US approves use of anti-viral drug for coronavirus treatment

WASHINGTON: The United States Food and Drug Administration (FDA) has authorised the emergency use of the Ebola drug remdesivir for treating the coronavirus. The authorisation means the anti-viral drug can now be used on people who are hospitalised with severe